Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-010938)

Filing Details

Accession Number:: 0001104659-20-010938
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-05 06:03:13
Reporting Period:: 2020-01-31

Accepted Time:: 2020-02-05 06:03:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477845	Annovis Bio Inc.	ANVS	Pharmaceutical Preparations (2834)	262540421

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1563273	Brian Jeffrey Mcgroarty	C/O Annovis Bio, Inc. 1055 Westlakes Drive, Suite 300 Berwyn PA 19312	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-01-31	33,333	$6.00	33,333	No	4	P	Direct
Common Stock	Acquisiton	2020-02-03	19,336	$7.15	52,669	No	4	P	Direct
Common Stock	Acquisiton	2020-02-03	164	$7.17	52,833	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The reporting person acquired these shares in the initial public offering of Annovis Bio, Inc.